Portland Engineering, Inc. v. ATG Pharma Inc.

CourtDistrict Court, D. Oregon
DecidedSeptember 10, 2020
Docket3:19-cv-02010
StatusUnknown

This text of Portland Engineering, Inc. v. ATG Pharma Inc. (Portland Engineering, Inc. v. ATG Pharma Inc.) is published on Counsel Stack Legal Research, covering District Court, D. Oregon primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Portland Engineering, Inc. v. ATG Pharma Inc., (D. Or. 2020).

Opinion

UNITED STATES DISTRICT COURT DISTRICT OF OREGON PORTLAND DIVISION

PORTLAND ENGINEERING, INC., an Case No. 3:19-cv-02010-AC Oregon corporation, and THOMPSON DUKE INDUSTRIAL, LLC, and Oregon OPINION AND ORDER limited liability company, Plaintiffs, v. ATG PHARMA INC., a Canadian corporation, Defendant,

ATG PHARMA INC., a Canadian corporation, Counter Claimant, Vv. PORTLAND ENGINEERING, INC., an Oregon corporation, and THOMPSON DUKE INDUSTRIAL, LLC, and Oregon limited liability company, Counter Defendants.

Page 1 — OPINION AND ORDER

ACOSTA, Magistrate Judge: Plaintiffs Portland Engineering Inc. (“PEI”) and Thompson Duke Industrial (“TDI”) (collectively “Plaintiffs”) bring action against Defendant ATG Pharma Inc. (“ATG”) alleging . infringement of US. Patent No. 10,440,989 (the “’989 patent”). Presently before the court are Plaintiffs’ Motion for Leave to File an Amended Complaint (ECF No. 48) and ATG’s Motion for Judgment on the Pleadings (ECF No. 47). For the following reasons, Plaintiffs’ motion is granted . and ATG’s motion is denied.

Background Plaintiffs manufacture and sell various machinery and hardware related to the manufacture of cannabis products. (Compl. 3.) PEI has expertise in the packaging and food and beverage industry, process automation, and hydrolics or flow of liquids. (Jd. 49.) At issue in this case is a patented vaporizer cartridge filling machine — an automated machine used for filling cartridges for use in vaporizer (“vape”) pens. (/d.). PEI developed an apparatus for automated filling of vape cartridges that allowed for a high degree of precision and control over the process. (Ud. □□□ 9-10.) PEI filed a patent application on November 1; 2016, and the ’989 patent issued on October 15,2019. Ud 410.) The ’989 patent contains forty-eight claims, with seven independent claims and forty-one dependent claims. (Ud., Ex. A.) . In November 2018, Michael J. Hogan, TDI Manager and co-inventor of patent °989, attended an MJBizcon convention in Las Vegas, Nevada. (Compl. § 12.) At the MJBizcon convention, Hogan found ATG Pharma displaying a vaporizer filling machine, RoboCAP RL-200, that appeared to embody the claimed invention and included components that were direct copies of Plaintiffs’ patented apparatus. Ud. § 12.) At the MJBizcon convention, the components copied by ATG also were displayed at a booth by a vendor named Greentank Technologies Page 2 — OPINION AND ORDER

(“Greentank”), a Canadian company that sells vape hardware. (/d.) Greentank advertises that it is “now partnered with ATG Pharma to supply retailers with cannabis oil filling machines that perfectly match our vape products.” (/d, & Ex. B.) After the MJBizcon convention, Hogan contacted Dustin Koffler, the Founder and CEO of Greentank, and explained that the ATG product displayed in its booth appeared to have been reverse engineered from PEI’s apparatus, and informed Koffler that PEI had filed a patent application. (Ud. § 13.) Koffler disavowed knowledge of the infringing product and directed Hogan to contact Mr. Michael Lio, ATG’s CEO. (Ud) On December 11, 2018, Mr. Lio sent Hogan an email acknowledging that he had been advised that ATG’s design potentially infringed Plaintiffs’ apparatus, and he requested a copy of the patent application. (Ud {¢ 13.) Plaintiffs contend that ATG’s RoboCAP products, the RoboCAP RL-200 and RoboCAP RL-300 (the “Accused Products”) are infringing claim 7 of the ’989 patent.

On December 10, 2019, Plaintiffs filed their Complaint alleging ATG infringed “one or more claims” in the ’989 patent. (Compl., ECF No. 1.) Plaintiffs specifically pleaded infringement of claim 7. (id. 415.) On February 7, 2020, ATG filed its Answer, Defenses and Counterclaims in which it contended claim 7 of the ’989 patent is invalid. (Answer, ECF No. 19.) On February 20, 2020, the court conducted a Rule 16 conference by telephone, at which it set several deadlines: (1) Initial disclosures to be served and conferral on Alternate Dispute Resolution by 4/3/2020; (2) Joint ESI Report and Protective Order due by 3/27/2020; (3) Joint ’ Alternate Dispute Resolution Report is due by 6/5/2020; (4) Amend pleadings and add parties by 6/5/2020; (5) Exchange Proposed Terms for Construction by 5/29/2020; (6) Exchange Preliminary Claim Constructions and Evidence by. 6/19/2020; (7) File Opening Claim Construction Briefs by 7/17/2020; (8) File Responsive Claim Construction Briefs by 8/7/2020; (9) Claims Construction Hearing is SET for Thursday, September 10, 2020 at 9:00 AM in Portland Courtroom 11B before Judge Acosta; (10) Fact Discovery is to be completed by Page 3 — OPINION AND ORDER

11/20/2020; (11) Expert Reports on Issues on which Party Bears Burden of Proof to be served by 1/22/2021; (12) Expert Reports on Issues on which Opposing Party Bears Burden of Proof to be served by 2/26/2021; (13) Expert Discovery to be completed by 3/26/2021; (14) Dispositive and Daubert Motions are due by 5/21/2021; (15) Final pretrial conference, filings and trial DEFERRED until after rulings made on Dispositive and Daubert motions; (16) The Court requests the parties notify the Court within 10 days as to whether they consent to magistrate. (Minutes of Proceedings, ECF No. 27.) On March 30, 2020, ATG filed a First Amended Answer, Defenses and Counterclaims. (Am. Answer, ECF No. 33.) ATG’s invalidity counterclaim asserts claim 7 is invalid as being anticipated by numerous commercially available piston volumetric filler machines with heated hoppers. (Jd. § 35.) ATG also seeks declaratory judgment of invalidity, non-infringement, and unenforceability of patent ’989. In early 2020, Hogan was in communication with Valens Agritech (“Valens”), a cannabis company in British Columbia.! (Decl. Casey Kniser (“Kniser Decl.”) Supp. Mot. Modify § 4, attached as Ex. B, ECF No. 48-1.) Valens informed Hogan that he possessed a RoboCAP apparatus; in early May 2020, Valens provided an “estimate” for the apparatus (Valens Estimate”). (id. 95.) The Valens Estimate came from Advanced Integrated Robotics (“AIR”), not ATG, which prompted Plaintiffs to further inquire. (Ud. J§ 5-6.) On May 8, 2020, Plaintiffs served a-document request on ATG in which they sought documents pertaining to AIR’s role in the design, development, manufacture, distribution, and advertising of RoboCAP products in the United States. (Ud. ¥ 6.) On June 8, 2020, ATG responded to Plaintiffs’ request by producing

The parties’ respective briefing do not disclose the exact date of the Hogan’s communication with Valens. From the information the parties have provided, it appears the communication occutred sometime between the filing of the Complaint in December 2019 and ATG’s Answerin □□□ February 2020. (Def.’s Opp’n at 6 n.2, ECF No. 53.) Page 4 — OPINION AND ORDER

eight invoices showing that AIR obtained Accused Products from ATG and shipped them to cannabis companies in the United States. (Ud. 47.) Upon additional inquiry, Plaintiffs learned that AIR was closely intertwined with ATG and that AIR’s only corporate officers, Devon Lio and Christopher Sharanewych, also are senior executives in ATG. Plaintiffs also learned that AIR and ATG operated from the same premises in Ontario, Canada, and that one of AIR’s corporate officers, Devon Lio, is ATG’s Director of Operations and the son of ATG’s CEO. (Ud. §§[ 9-10.) Additionally, Sharanewych is the Vice President of Business Development for ATG, and Sharanewych and Devon Lio were college roommates. (Ud. { 12.) On May 14, 2020, ATG served a second set of interrogatories in which it asked Plaintiffs to identify each claim in the ’989 patent they contended was infringed. (Ud. 1-3.) Pursuant to the court’s scheduling order, the parties exchanged proposed claim terms for construction on May _ 29, 2020. (Scheduling Order, ECF Nos.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Foman v. Davis
371 U.S. 178 (Supreme Court, 1962)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
McZeal v. Sprint Nextel Corp.
501 F.3d 1354 (Federal Circuit, 2007)
Jose Chavez v. James Ziglar
683 F.3d 1102 (Ninth Circuit, 2012)
Pit River Tribe v. Bureau of Land Management
793 F.3d 1147 (Ninth Circuit, 2015)
Nalco Company v. Chem-Mod, LLC
883 F.3d 1337 (Federal Circuit, 2018)
Disc Disease Solutions Inc. v. Vgh Solutions, Inc.
888 F.3d 1256 (Federal Circuit, 2018)
Danica Brown v. Stored Value Cards, Inc.
953 F.3d 567 (Ninth Circuit, 2020)
Coleman v. Quaker Oats Co.
232 F.3d 1271 (Ninth Circuit, 2000)
Erhart v. Bofi Holding, Inc.
387 F. Supp. 3d 1046 (S.D. California, 2019)
Kenall Mfg. Co. v. Cooper Lighting, LLC
354 F. Supp. 3d 877 (E.D. Illinois, 2018)
Starr v. Baca
652 F.3d 1202 (Ninth Circuit, 2011)
Wizards of the Coast LLC v. Cryptozoic Entertainment LLC
309 F.R.D. 645 (W.D. Washington, 2015)

Cite This Page — Counsel Stack

Bluebook (online)
Portland Engineering, Inc. v. ATG Pharma Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/portland-engineering-inc-v-atg-pharma-inc-ord-2020.